🔎 Trials Near Me

Gara Jalqabaatti › Carcinoma Basal Cell

Qorannoo klinikaalii Carcinoma Basal Cell Ameerikaa Keessatti hirmaatuu

Qorannoo 20 Carcinoma Basal Cell f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT07182240

Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Hag-2026 · NCT05896839

Two-photon Fluorescence Microscopy of Dermatologic Biopsies

Namoota walitti qabaa jira
Umuriin hundi · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07773688

Machine Learning Analysis of Two-photon Fluorescence Microscopy of Dermatologic Biopsies

Namoota walitti qabaa jira
Umuriin hundi · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT07682831

Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 18-Hag-2026 · NCT07241585

A Study of MQ710 With and Without Pembrolizumab in People With Solid Tumor Cancer

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT05859074

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT05592626

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT07227350

Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT07628634

Neoadjuvant Nivolumab + Relatlimab (Opdualag) Versus Nivolumab for Resectable High-Risk Basal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ado-2026 · NCT06624475

L19IL2/TNF in Patients With Basal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Ado-2026 · NCT07227870

A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients

Namoota walitti qabaa jiraSadarkaa jalqabaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Wax-2026 · NCT07286318

Raman Spectroscopy and Skin Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Cam-2026 · NCT06384924

Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Elb-2026 · NCT03521830

Blue-Light Photodynamic Therapy and Sonidegib for Multiple Basal Cell Carcinomas

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 29-Ama-2026 · NCT06623201

Treating Basal and Squamous Cell Carcinomas With Fractional Laser and Tirbanibulin Ointment

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2025 · NCT07010692

A Beta-only IL-2 ImmunoTherapY Study

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 09-Ado-2025 · NCT05086692

Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy

Namoota walitti qabaa jira
Umuriin hundi · Saalaa hunda · Haaromfame 17-Bit-2025 · NCT06473103

To Assess the Safety and Efficacy of SP-002 with Vismodegib for the Treatment of Locally Advanced Basal Cell Carcinoma

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Ful-2024 · NCT06344052

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.